Key Takeaways
- • Bain Capital has agreed to acquire Vitabiotics, the UK's leading vitamin and supplements manufacturer, in a deal valued at approximately £900 million to £1 billion, with transaction signing completed in July 2026.
- • Vitabiotics operates an established international portfolio of consumer health and nutritional supplement products with significant presence in India through Meyer Organics, positioning the company within the accelerating deal activity across the nutraceuticals and preventive-health sector.
- • A&O Shearman advised arrangers on committed financing for the acquisition, leveraging cross-border leveraged finance capabilities across Singapore, Hong Kong, and the wider Asia-Pacific region to execute a multi-jurisdictional sponsor-backed transaction.
- • The transaction reflects sustained investor appetite for preventive health and wellness exposure, with Bain Capital's acquisition supporting the next phase of Vitabiotics' global expansion strategy amid growing consumer demand for nutritional supplements.
Summary
Bain Capital has secured committed financing for its proposed acquisition of Vitabiotics, a London-headquartered vitamins and supplements manufacturer and the UK's leading vitamin brand. The transaction, which was signed in July 2026, is valued at approximately £900 million to £1 billion and remains subject to customary regulatory approvals. A&O Shearman served as legal counsel to the arrangers providing the committed financing, marking a significant engagement in the consumer health sector.
Vitabiotics has established itself as a major player in the nutraceuticals market through a diversified international portfolio of consumer health and nutritional supplement products. The company maintains a notable footprint in India via Meyer Organics, expanding its geographic reach beyond its UK base. The acquisition aligns with Bain Capital's strategic focus on sectors offering sustained growth potential, particularly preventive health and wellness—categories experiencing accelerating investor interest and deal activity globally.
The financing structure required sophisticated cross-border execution, reflecting the complexity of modern sponsor-backed transactions. A&O Shearman's engagement spanned Singapore, Hong Kong, and the broader Asia-Pacific region, demonstrating the multi-jurisdictional nature of contemporary large-cap private equity financings. Matt Del Rosso, A&O Shearman partner in Singapore, noted that "financings of this scale demand seamless execution across markets and an ability to navigate the evolving terms of sponsor-backed transactions in Asia-Pacific." The legal team was led by partners Del Rosso and Gautam Narasimhan in Singapore and Daniel Tan in Hong Kong, supported by associates and trainees.
Bain Capital's acquisition of Vitabiotics underscores the strategic rationale behind investor interest in the consumer health sector, where demand for preventive wellness products continues to expand. The transaction supports Vitabiotics' next phase of global growth while providing Bain Capital with exposure to established consumer brands with international distribution networks. The deal exemplifies the continued strength of sponsor-backed M&A activity in Asia-Pacific and broader emerging markets, where financial buyers increasingly seek sophisticated multi-jurisdictional financing solutions.
Vitabiotics has established itself as a major player in the nutraceuticals market through a diversified international portfolio of consumer health and nutritional supplement products. The company maintains a notable footprint in India via Meyer Organics, expanding its geographic reach beyond its UK base. The acquisition aligns with Bain Capital's strategic focus on sectors offering sustained growth potential, particularly preventive health and wellness—categories experiencing accelerating investor interest and deal activity globally.
The financing structure required sophisticated cross-border execution, reflecting the complexity of modern sponsor-backed transactions. A&O Shearman's engagement spanned Singapore, Hong Kong, and the broader Asia-Pacific region, demonstrating the multi-jurisdictional nature of contemporary large-cap private equity financings. Matt Del Rosso, A&O Shearman partner in Singapore, noted that "financings of this scale demand seamless execution across markets and an ability to navigate the evolving terms of sponsor-backed transactions in Asia-Pacific." The legal team was led by partners Del Rosso and Gautam Narasimhan in Singapore and Daniel Tan in Hong Kong, supported by associates and trainees.
Bain Capital's acquisition of Vitabiotics underscores the strategic rationale behind investor interest in the consumer health sector, where demand for preventive wellness products continues to expand. The transaction supports Vitabiotics' next phase of global growth while providing Bain Capital with exposure to established consumer brands with international distribution networks. The deal exemplifies the continued strength of sponsor-backed M&A activity in Asia-Pacific and broader emerging markets, where financial buyers increasingly seek sophisticated multi-jurisdictional financing solutions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.